|
Index of reports
> Cases resulting in disability (19)
> Cases with Renal Impairment (5)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in disability where reactions include renal impairment.
Adverse event in 74 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-05-22
Patient: 74 year old male
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: disablity
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-06-01
End date: 2003-09-22
Epivir
Dosage: 300mg per day
Administration route: Oral
Start date: 2005-05-23
End date: 2005-07-25
Epivir
Dosage: 150mg per day
Administration route: Oral
Start date: 2005-11-29
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Other drugs received by patient: Ziagen; Norvir; Reyataz; Baktar
Adverse event in 74 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-22
Patient: 74 year old male
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: disablity
Suspect drug(s):
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-29
Epivir
Dosage: 05-may-05 to 25-jul-05, restarted on 29-nov-05 to unknown
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Other drugs received by patient: Baktar; Ziagen; Norvir
Adverse event in 31 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-28
Patient: 31 year old male
Adverse reactions / side effects: Renal Impairment, Schizophrenia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2003-03-28
End date: 2004-05-27
Epivir
Dosage: dosing began 20-apr-05. interrupted 27-may-2004. restarted 20-apr-2005. discontinued 13-jun-2005.
Administration route: Oral
Indication: HIV Infection
Start date: 2003-03-28
End date: 2005-06-13
Retrovir
Dosage: decreased to 400 mg od, from 06-may-03 to 27-may-04.
Administration route: Oral
Indication: HIV Infection
Start date: 2003-03-28
End date: 2004-05-27
Other drugs received by patient: Penfill
Adverse event in 74 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-02-26
Patient: 74 year old male
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: disablity
Suspect drug(s):
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-29
Epivir
Dosage: 05-may-05 to 25-jul-05, restarted on 29-nov-05 to unknown
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Other drugs received by patient: Baktar; Ziagen; Norvir
Adverse event in 74 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-02-19
Patient: 74 year old male
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: disablity
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-06-01
End date: 2003-09-22
Epivir
Dosage: 300mg per day
Administration route: Oral
Start date: 2005-05-23
End date: 2005-07-25
Epivir
Dosage: 150mg per day
Administration route: Oral
Start date: 2005-11-29
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-29
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Other drugs received by patient: Ziagen; Norvir; Baktar
|
